Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa

被引:65
|
作者
Gaziano, T. A. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
关键词
D O I
10.1136/hrt.2007.128785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death in those over the age of 45 in Africa. The economic toll from cardiovascular diseases is equally devastating, leading to billions of dollars lost due to healthcare costs and reduced productivity from the disabling and fatal outcomes related to diabetes, hypertension, stroke, valvular heart disease, and heart failure. Much of it is preventable. With reasonable screening programmes and judicious use of scarce resources much of the suffering can be alleviated. This article reviews the economic burden attributable to cardiovascular disease in Africa and many of the potential cost-effective solutions to the large burden. It further outlines many of the areas where we know less and must focus our future research in trying to outline cost-effective solutions.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 50 条
  • [41] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Wong, Alyson W.
    Koo, John
    Ryerson, Christopher J.
    Sadatsafavi, Mohsen
    Chen, Wenjia
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [42] COST-EFFECTIVENESS ANALYSIS OF OPIOID SUBSTITUTION TREATMENT IN REPUBLIC OF SOUTH AFRICA
    Hren, R.
    Milanic, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A711 - A712
  • [43] Economic foundations of cost-effectiveness analysis
    Garber, AM
    Phelps, CE
    [J]. JOURNAL OF HEALTH ECONOMICS, 1997, 16 (01) : 1 - 31
  • [44] Cost-Effectiveness and Economic Benefits of Volunteerism
    Persaud, Satyendra
    Chisholm, Leah
    [J]. CURRENT BLADDER DYSFUNCTION REPORTS, 2020, 15 (04) : 362 - 365
  • [45] Cost-Effectiveness and Economic Benefits of Volunteerism
    Satyendra Persaud
    Leah Chisholm
    [J]. Current Bladder Dysfunction Reports, 2020, 15 : 362 - 365
  • [46] A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases
    Huoponen, Saara
    Blom, Marja
    [J]. PLOS ONE, 2015, 10 (12):
  • [47] THE COST-EFFECTIVENESS OF BIOLOGICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW
    Huoponen, S.
    Blom, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A668 - A668
  • [48] COST-EFFECTIVENESS OF THE TREATMENT OF RESPIRATORY DISEASES OF XIYANPING INJECTION : A SYSTEMATIC REVIEW
    Chen, X. F.
    Huang, S. T.
    Zhu, W. F.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A779 - A779
  • [49] The Rationale for Economic Evaluation in Speech and Language: Cost, Effectiveness, and Cost-effectiveness
    Hoch, Jeffrey S.
    Smith, Bridgette P.
    Kim, Jiyeong
    Dewa, Carolyn S.
    [J]. SEMINARS IN SPEECH AND LANGUAGE, 2022, 43 (03) : 208 - 217
  • [50] Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation
    Moore, David J.
    Adi, Yaser
    Connock, Martin J.
    Bayliss, Sue
    [J]. BMC ENDOCRINE DISORDERS, 2009, 9 : 20